131 related articles for article (PubMed ID: 9842899)
1. Progressive loss of IL-2-expandable HIV-1-specific cytotoxic T lymphocytes during asymptomatic HIV infection.
Jin X; Wills M; Sissons JG; Carmichael A
Eur J Immunol; 1998 Nov; 28(11):3564-76. PubMed ID: 9842899
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
Carmichael A; Jin X; Sissons P; Borysiewicz L
J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1 (HIV-1)--and Epstein-Barr virus--specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1--infected persons.
Geretti AM; Dings ME; van Els CA; van Baalen CA; Wijnholds FJ; Borleffs JC; Osterhaus AD
J Infect Dis; 1996 Jul; 174(1):34-45. PubMed ID: 8656011
[TBL] [Abstract][Full Text] [Related]
4. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
Enssle KH; Fleischer B
Clin Exp Immunol; 1990 Mar; 79(3):409-15. PubMed ID: 1690617
[TBL] [Abstract][Full Text] [Related]
5. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
[TBL] [Abstract][Full Text] [Related]
6. Activation of HLA-restricted EBV-specific cytotoxic T cells does not require CD4+ (helper) T cells or exogenous cytokines.
Fishwild DM; Benike CJ; Engleman EG
J Immunol; 1988 Mar; 140(6):1994-8. PubMed ID: 2831276
[TBL] [Abstract][Full Text] [Related]
7. IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp).
Ferrari G; King K; Rathbun K; Place CA; Packard MV; Bartlett JA; Bolognesi DP; Weinhold KJ
Clin Exp Immunol; 1995 Aug; 101(2):239-48. PubMed ID: 7544247
[TBL] [Abstract][Full Text] [Related]
8. The role of CD4+ T cell help and CD40 ligand in the in vitro expansion of HIV-1-specific memory cytotoxic CD8+ T cell responses.
Ostrowski MA; Justement SJ; Ehler L; Mizell SB; Lui S; Mican J; Walker BD; Thomas EK; Seder R; Fauci AS
J Immunol; 2000 Dec; 165(11):6133-41. PubMed ID: 11086046
[TBL] [Abstract][Full Text] [Related]
9. Lack of correlation between phenotype activation markers of CD8 lymphocytes and cytotoxic T lymphocyte (CTL) function in HIV-1 infection: evidence for rescue with rIL-2.
Chia WK; Nisbet-Brown E; Li X; Salit I; Joshi S; Read SE
Viral Immunol; 1994; 7(2):81-95. PubMed ID: 7848511
[TBL] [Abstract][Full Text] [Related]
10. CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice.
Jennings SR; Bonneau RH; Smith PM; Wolcott RM; Chervenak R
Cell Immunol; 1991 Mar; 133(1):234-52. PubMed ID: 1671342
[TBL] [Abstract][Full Text] [Related]
11. The anti-idiotypic antibody 1F7 selectively inhibits cytotoxic T cells activated in HIV-1 infection.
Grant M; Smaill F; Muller S; Kohler H; Rosenthal K
Immunol Cell Biol; 2000 Feb; 78(1):20-7. PubMed ID: 10651925
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma.
Kersten MJ; Klein MR; Holwerda AM; Miedema F; van Oers MH
J Clin Invest; 1997 Apr; 99(7):1525-33. PubMed ID: 9119996
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
Muraoka S
Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
[TBL] [Abstract][Full Text] [Related]
14. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
[TBL] [Abstract][Full Text] [Related]
15. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD
AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T-lymphocytes that kill autologous CD4+ lymphocytes are associated with CD4+ lymphocyte depletion in HIV-1 infection.
Grant MD; Smail FM; Rosenthal KL
J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):571-9. PubMed ID: 7909845
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 replication, immune activation, and circulating cytotoxic T cells against uninfected CD4+ T cells.
Kottilil S; Gamberg J; Bowmer I; Trahey J; Howley C; Gallant M; Grant M
J Clin Immunol; 2000 May; 20(3):175-86. PubMed ID: 10941825
[TBL] [Abstract][Full Text] [Related]
18. Human immune response to HIV-1-Nef. I. CD45RO- T lymphocytes of non-infected donors contain cytotoxic T lymphocyte precursors at high frequency.
Lucchiari M; Niedermann G; Leipner C; Meyerhans A; Eichmann K; Maier B
Int Immunol; 1994 Nov; 6(11):1739-49. PubMed ID: 7865467
[TBL] [Abstract][Full Text] [Related]
19. Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors.
Lalvani A; Dong T; Ogg G; Patham AA; Newell H; Hill AV; McMichael AJ; Rowland-Jones S
J Immunol Methods; 1997 Dec; 210(1):65-77. PubMed ID: 9502585
[TBL] [Abstract][Full Text] [Related]
20. OX40 ligation of CD4+ T cells enhances virus-specific CD8+ T cell memory responses independently of IL-2 and CD4+ T regulatory cell inhibition.
Yu Q; Yue FY; Gu XX; Schwartz H; Kovacs CM; Ostrowski MA
J Immunol; 2006 Feb; 176(4):2486-95. PubMed ID: 16456009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
